Jefferies Group acquired 1.5 Million Agios Pharmaceuticals shares worth $42 Million. That's 0.59% of their equity portfolio (32nd largest holding). The investor owns 2.65% of the outstanding Agios Pharmaceuticals stock. The investor's estimated purchase price is $70.1 Million, resulting in a loss of 40%.